More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$9.20B
EPS
3.17
P/E ratio
24.7
Price to sales
0.71
Dividend yield
--
Beta
0.883055
Previous close
$78.43
Today's open
$78.24
Day's range
$77.47 - $79.58
52 week range
$60.56 - $82.80
show more
CEO
Stanley M. Bergman
Employees
25000
Headquarters
Melville, NY
Exchange
Nasdaq Global Select
Shares outstanding
117724807
Issue type
Common Stock
Healthcare
Medical Distributors
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program
HOUSTON--(BUSINESS WIRE)--The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children's lives through this access-to-oral-health-care initiative. What began as a local grassroots movement in St. Louis, MO, has evolved into a national movement, having served more than 10.2 million underserved children since 2003. GKAS begins nationally in February, which is National C.
Business Wire • Feb 6, 2026

Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter 2025 financial results before the stock market opens on Tuesday, February 24, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the B.
Business Wire • Jan 22, 2026

Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer
IRVINE, Calif.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care.
Business Wire • Jan 15, 2026

Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha • Jan 14, 2026

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Jan 13, 2026

Henry Schein Names Frederick M. Lowery as Chief Executive Officer
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (“CEO”), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and ef.
Business Wire • Jan 12, 2026

HSIC or SAUHY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Straumann Holding AG (SAUHY). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Jan 6, 2026

One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan
Chicago-based Zuckerman Investment Group increased its Henry Schein position by 72,040 shares in the third quarter. The overall position value went up by about $3.38 million from the previous period.
The Motley Fool • Dec 29, 2025

Henry Schein to Participate in the J.P. Morgan Conference in January
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in January: J.P. Morgan's Healthcare Investor Conference on Tuesday, January 13, 2026, at 3:00 p.m. PST / 6:00 p.m. EST, at The Westin St. Francis hotel in San Francisco. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.c.
Business Wire • Dec 29, 2025

Henry Schein Provides Update on CEO Search Process
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint the Company's next CEO by mid-January 2026. Philip A. Laskawy, Lead Director for Henry Schein said, “We are pleased with the progress we have made in our search for Henry Schein's next CEO. The search process is nearing completion but will not be finalized before year.
Business Wire • Dec 23, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Henry Schein Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.